(Q35548273)

English

Utility of disease modifying antirheumatic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 years

scientific article published on October 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Utility of disease modifying antirheumatic drugs in "sawtooth" strategy. A prospective study of early rheumatoid arthritis patients up to 15 years (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

rheumatoid arthritis

0 references

author name string

Sokka T

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Hannonen P

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

618-622

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

A retrospective study of treating RA patients with various combinations of slow-acting antirheumatic drugs in a county hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Practical results of treatment with disease-modifying antirheumatoid drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Remodeling the pyramid--a concept whose time has come

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis--lessons from Hodgkin's disease and coronary artery disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Long-term second-line treatment: a prospective drug survival study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752781

12 July 2018

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1958 REVISION of diagnostic criteria for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remodeling the pyramid--a concept whose time has not yet come

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early rheumatoid arthritis--onset, course, and outcome over 2 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: a contemporary goal for rheumatology care?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10491360

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.58.10.618

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

release_eghlhf7rsvfq7e46d6gav2aksa

1 reference

https://api.fatcat.wiki/v0/release/eghlhf7rsvfq7e46d6gav2aksa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35548273&oldid=1836739544"